TILT Biotherapeutics
TILT Biotherapeutics is a biotechnology company developing t-cell therapies using onolytic viruses for treating cancer.
2
Funding Rounds
$22.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ak**** He****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company TILT Biotherapeutics has raised a total of $22m in funding over 2 rounds.
Key Insights:
- TILT Biotherapeutics February 2023 Series A Funding Round: $11m
- TILT Biotherapeutics December 2016 Seed Funding Round: $11m
TILT Biotherapeutics February 2023 Series A Funding Round
$11m
TILT Biotherapeutics December 2016 Seed Funding Round
$11m
Industries
TILT Biotherapeutics is active in the following industries: